Global GI Stool Testing Market Growth (Status and Outlook) 2023-2029

Global GI Stool Testing Market Growth (Status and Outlook) 2023-2029

Stools tests are performed to diagnose the GI tract disorders and aid in the detection of parasites infection, bleeding obstruction, and inflammation. Stools tests can further be utilized for diagnosis of colorectal cancer or presence of pathogens such as Rotavirus, C. difficile, H. pylori among others in the GI tract. Laboratory tests used for the stool testing are either microbial particle-based or antibody-based, which include chemiluminescence immunoassays (CLIA), immunoassay and molecular diagnostic testing.

LPI (LP Information)' newest research report, the “GI Stool Testing Industry Forecast” looks at past sales and reviews total world GI Stool Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected GI Stool Testing sales for 2023 through 2029. With GI Stool Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GI Stool Testing industry.

This Insight Report provides a comprehensive analysis of the global GI Stool Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GI Stool Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GI Stool Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GI Stool Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GI Stool Testing.

The global GI Stool Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Increased incidence of C. difficile infections and other gastrointestinal diseases increases the demand for stool tests, thereby driving the global GI stool testing market. According to the Centers for Disease Control and Prevention, in 2014, an estimated of 14.8 million adults were diagnosed with ulcers and other digestive disorders in the United States. Furthermore, in 2017, 135,430 new cases of colorectal cancer were diagnosed in the country, raising the demand for GI stool testing. However, the challenge of accurate testing restrains the market.

This report presents a comprehensive overview, market shares, and growth opportunities of GI Stool Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Microscopy Tests
Ova & Parasites Test
Occult Blood Test
Stool Biomarkers Tests
Others

Segmentation by application
Hospitals
Diagnostics Centers and Laboratories
Research Centers and Academic Institutions

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Clinical Genomics
Diasorin
Meridian Bioscience
Quidel
bioMerieux
Cenogenics
EIKEN CHEMICAL
Helena Laboratories
Hemosure
Mobidiag
Orion Diagnostica
Pinnacle BioLabs
Polymedco
ScheBo Biotech

Please note: The report will take approximately 2 business days to prepare and deliver.